Form 13-F position report

BIOANALYTICAL SYSTEMS INC

Reported by ACADIAN ASSET MANAGEMENT LLC

NOTV CUSIP 09058M103 Manager CIK 0000916542

Reported 0 shares, down 63,849 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q3 2020
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 19 Through Q3 2020

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for BIOANALYTICAL SYSTEMS INC held by ACADIAN ASSET MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

23 managers reported BIOANALYTICAL SYSTEMS INC for Q3 2020.

Managers reporting BIOANALYTICAL SYSTEMS INC in Q3 2020.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 520,193 +70,566 < 0.01% $2,487,000 30 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 500,014 -3,392 < 0.01% $2,390,000 23 qtrs
BRIDGEWAY CAPITAL MANAGEMENT LLC Unchanged 67,510 0 < 0.01% $323,000 14 qtrs
BlackRock Inc Added 30,722 +3,068 < 0.01% $146,000 15 qtrs
Versant Capital Management Inc Unchanged 19,191 0 0.04% $91,000 12 qtrs
UBS Group AG Reduced 12,331 -1,329 < 0.01% $59,000 8 qtrs
NORTHERN TRUST CORPORATION New 10,401 +10,401 < 0.01% $50,000 1 qtr
NORTH STAR ASSET MANAGEMENT INC Unchanged 10,000 0 < 0.01% $48,000 30 qtrs
Tower Research Capital LLC TRC New 966 +966 < 0.01% $5,000 1 qtr
CHIRON CAPITAL MANAGEMENT LLC New 1,100 +1,100 < 0.01% $5,000 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2020
Filed
November 09, 2020
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.